Doongaji D R, Jeste D V, Jape N M, Sheth A S, Apte J S, Vahia V N, Desai A B, Vahora S A, Thatte S, Vevaina T, Bharadwaj J
J Clin Psychopharmacol. 1982 Oct;2(5):341-4.
We screened the entire inpatient population (N = 1963) of a state hospital near Bombay, India, for tardive dyskinesia (TD) using specific diagnostic criteria. Prevalence of TD was found to be 9.6%, which was much lower than that reported from the Western countries. Percent prevalence of TD was greatest in the age group 41 to 50, after which it seemed to decline. TD patients had received neuroleptic treatment for significantly longer periods and in significantly greater amounts than non-TD patients. The principal reason for the relatively low prevalence of TD in India is probably the practice of using neuroleptics in comparatively small doses (mean daily dose is about 200 mg of chlorpromazine equivalents). A possible contribution of racial-genetic factors cannot be excluded.
我们使用特定诊断标准,对印度孟买附近一家国立医院的全部住院患者(N = 1963)进行了迟发性运动障碍(TD)筛查。发现TD的患病率为9.6%,远低于西方国家报告的患病率。TD患病率在41至50岁年龄组中最高,此后似乎有所下降。TD患者接受抗精神病药物治疗的时间明显更长,剂量也明显更大。印度TD患病率相对较低的主要原因可能是使用抗精神病药物的剂量相对较小(平均每日剂量约为200毫克氯丙嗪当量)。种族遗传因素的可能作用也不能排除。